NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue5,3196,4823,7672,398
Cost of Revenue49,61547,99423,6049,355
Gross Profit-44,296-41,512-19,837-6,957
Operating Expenses
Research Development----
Selling General and Administrative29,47213,5357,9213,739
Non Recurring----
Others----
Total Operating Expenses79,08761,52931,52513,094
Operating Income or Loss-73,768-55,047-27,758-10,696
Income from Continuing Operations
Total Other Income/Expenses Net767-515-19,651-3,432
Earnings Before Interest and Taxes-73,768-55,047-27,758-10,696
Interest Expense-43-75-22,092-2,910
Income Before Tax-73,001-55,562-47,409-14,128
Income Tax Expense1,355-672-44594
Minority Interest----
Net Income From Continuing Ops-74,356-54,890-46,964-14,222
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-74,356-54,890-46,964-14,222
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-74,356-54,890-50,839-14,414